Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2025 Filed Sep 8, 2025 20:54 UTC |
KING THOMAS BRAXTONDirector
|
SaleCommon Stock | 139,858 | $2.77 | $387,406.66 |
DisclosureSEC source: 0000950170-25-113591 · ownership.xml · nonDerivative · entry 2 KING THOMAS BRAXTON · CIK 0001279309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,142 F2 · shares: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:54 UTC |
KING THOMAS BRAXTONDirector
|
Exercise / conversionCommon Stock | 455,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113591 · ownership.xml · nonDerivative · entry 1 KING THOMAS BRAXTON · CIK 0001279309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:51 UTC |
JACOBS CINDYPresident & CMO
|
Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113588 · ownership.xml · derivative · entry 4 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Stock · 26,000 shares Expires 2035-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F8 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:51 UTC |
JACOBS CINDYPresident & CMO
|
Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113588 · ownership.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,000 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F6 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:51 UTC |
JACOBS CINDYPresident & CMO
|
SaleCommon Stock | 27,629 | $2.77 | $76,532.33 |
DisclosureSEC source: 0000950170-25-113588 · ownership.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,585 F2 · shares: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:51 UTC |
JACOBS CINDYPresident & CMO
|
Exercise / conversionCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113588 · ownership.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 21:01 UTC |
Slaoui Kristen B.Director
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0000950170-25-084439 · ownership.xml · derivative · entry 1 Slaoui Kristen B. · CIK 0002050928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2035-06-06 F1 · derivative.exercise_date: The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:58 UTC |
Phelan Nancy R.Director
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0000950170-25-084427 · ownership.xml · derivative · entry 1 Phelan Nancy R. · CIK 0001750316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2035-06-06 F1 · derivative.exercise_date: The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:55 UTC |
Sellig ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0000950170-25-084423 · ownership.xml · derivative · entry 1 Sellig Thomas · CIK 0001969416 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2035-06-06 F1 · derivative.exercise_date: The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:51 UTC |
Martell Bridget ADirector
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0000950170-25-084420 · ownership.xml · derivative · entry 1 Martell Bridget A · CIK 0001629627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2035-06-06 F1 · derivative.exercise_date: The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:45 UTC |
Duty StuartDirector
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0000950170-25-084407 · ownership.xml · derivative · entry 1 Duty Stuart · CIK 0001970274 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2035-06-06 F1 · derivative.exercise_date: The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:48 UTC |
KING THOMAS BRAXTONDirector
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0000950170-25-084415 · ownership.xml · derivative · entry 1 KING THOMAS BRAXTON · CIK 0001279309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2035-06-06 F1 · derivative.exercise_date: The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:38 UTC |
Oki Mark KChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $2.89 | $28,887.00 |
DisclosureSEC source: 0000950170-25-042074 · ownership.xml · nonDerivative · entry 1 Oki Mark K · CIK 0001491847 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.9387 per share, inclusive. The Rreporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:32 UTC |
Stewart Richard AlistairDirector · Chieve Executive Officer
|
PurchaseCommon Stock | 10,000 | $2.86 | $28,598.00 |
DisclosureSEC source: 0000950170-25-042060 · ownership.xml · nonDerivative · entry 1 Stewart Richard Alistair · CIK 0001713369 · Director · Chieve Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,876 F1 · balance_after: In January 2025, pursuant to an agreement between the Reporting Person and the Issuer, the Reporting Person relinquished the stock option to purchase 67,500 shares of the Issuer's common stock granted on January 13, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:54 UTC |
Wan JerryPrincipal Accounting Officer
|
GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 48,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011164 · ownership.xml · derivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2035-01-28 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:50 UTC |
JACOBS CINDYDirector · President & CMO
|
GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011156 · ownership.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2035-01-28 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:51 UTC |
Xinos JaimeChief Commercial Officer
|
GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011159 · ownership.xml · derivative · entry 1 Xinos Jaime · CIK 0002041627 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-01-28 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:46 UTC |
Slaoui Kristen B.Director
|
GrantStock Option (right to buy) · Derivative | 47,250 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0000950170-25-005405 · ownership.xml · derivative · entry 1 Slaoui Kristen B. · CIK 0002050928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,250 Underlying: Common Stock · 47,250 shares Expires 2035-01-13 F1 · derivative.exercise_date: The option will vest in substantially equal monthly installments over 36 months commencing January 6, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:46 UTC |
Phelan Nancy R.Director
|
GrantStock Option (right to buy) · Derivative | 47,250 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0000950170-25-005404 · ownership.xml · derivative · entry 1 Phelan Nancy R. · CIK 0001750316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,250 Underlying: Common Stock · 47,250 shares Expires 2035-01-13 F1 · derivative.exercise_date: The option will vest in substantially equal monthly installments over 36 months commencing January 6, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:43 UTC |
Stewart Richard AlistairDirector · Chieve Executive Officer
|
GrantStock Option (right to buy) · Derivative | 67,500 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0000950170-25-005398 · ownership.xml · derivative · entry 2 Stewart Richard Alistair · CIK 0001713369 · Director · Chieve Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2035-01-13 F3 · derivative.exercise_date: The option will vest as to 1/3 of the total award on the first anniversary of August 26, 2024, and thereafter in substantially equal monthly installments over 24 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:43 UTC |
Stewart Richard AlistairDirector · Chieve Executive Officer
|
GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 157,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-005398 · ownership.xml · derivative · entry 1 Stewart Richard Alistair · CIK 0001713369 · Director · Chieve Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,500 Underlying: Common Stock · 157,500 shares Expires 2029-01-13 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met. The PRSUs will lapse in full if achievement of at least one of the milestones is not met. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:41 UTC |
Xinos JaimeChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0000950170-25-005389 · ownership.xml · derivative · entry 1 Xinos Jaime · CIK 0002041627 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-01-13 F1 · derivative.exercise_date: The option will vest as to 1/4 of the total award on the first anniversary of December 6, 2024, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:42 UTC |
KING THOMAS BRAXTONDirector · Executive Chairman
|
GrantStock Option (right to buy) · Derivative | 195,000 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0000950170-25-005392 · ownership.xml · derivative · entry 2 KING THOMAS BRAXTON · CIK 0001279309 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Stock · 195,000 shares Expires 2035-01-13 F3 · derivative.exercise_date: The option will vest as to 1/4 of the total award on the first anniversary of August 26, 2024, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:42 UTC |
KING THOMAS BRAXTONDirector · Executive Chairman
|
GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 455,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-005392 · ownership.xml · derivative · entry 1 KING THOMAS BRAXTON · CIK 0001279309 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455,000 Underlying: Common Stock · 455,000 shares Expires 2029-01-13 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met. The PRSUs will lapse in full if achievement of at least one of the milestones is not met. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 21:45 UTC |
Xinos JaimeChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0000950170-24-134606 · ownership.xml · derivative · entry 1 Xinos Jaime · CIK 0002041627 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-12-06 F1 · derivative.exercise_date: The options vest 25% on the first anniversary of December 6, 2024 and thereafter in monthly installments over 36 months. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 21:39 UTC |
Oki Mark KChief Financial Officer
|
GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 168,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-134600 · ownership.xml · derivative · entry 2 Oki Mark K · CIK 0001491847 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,000 Underlying: Common Stock · 168,000 shares Expires 2028-12-06 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F3 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met. The PRSUs will lapse in full if achievement of at least one of the milestones is not met. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 21:39 UTC |
Oki Mark KChief Financial Officer
|
GrantCommon Stock Options (right to buy) · Derivative | 72,000 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0000950170-24-134600 · ownership.xml · derivative · entry 1 Oki Mark K · CIK 0001491847 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2034-12-06 F1 · derivative.exercise_date: The options vest one-third on the first anniversay of December 5, 2024 and thereafter in monthly installments over 24 months. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:11 UTC |
Wan JerryPrincipal Accounting Officer
|
GrantCommon Stock | 2,857 | $3.67 | $10,485.19 |
DisclosureSEC source: 0000950170-24-099091 · ownership.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,664 F1 · kind: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:07 UTC |
JACOBS CINDYDirector · President & CMO
|
GrantCommon Stock | 2,660 | $3.67 | $9,762.20 |
DisclosureSEC source: 0000950170-24-099082 · ownership.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,214 F1 · kind: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:05 UTC |
Bencich JohnDirector · CEO
|
GrantCommon Stock | 5,000 | $3.67 | $18,350.00 |
DisclosureSEC source: 0000950170-24-099074 · ownership.xml · nonDerivative · entry 1 Bencich John · CIK 0001477056 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,636 F1 · kind: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:39 UTC |
Wan JerryPrincipal Accounting Officer
|
Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046984 · ownership.xml · derivative · entry 3 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,625 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:39 UTC |
Wan JerryPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 2,250 | $4.51 | $10,147.50 |
DisclosureSEC source: 0000950170-24-046984 · ownership.xml · nonDerivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,807 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:39 UTC |
Wan JerryPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046984 · ownership.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:35 UTC |
JACOBS CINDYDirector · President & CMO
|
Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046974 · ownership.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,250 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:35 UTC |
JACOBS CINDYDirector · President & CMO
|
Tax withholdingCommon Stock | 3,957 | $4.51 | $17,846.07 |
DisclosureSEC source: 0000950170-24-046974 · ownership.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,554 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:35 UTC |
JACOBS CINDYDirector · President & CMO
|
Exercise / conversionCommon Stock | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046974 · ownership.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:31 UTC |
Stewart Richard AlistairDirector · Executive Chairman
|
Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046962 · ownership.xml · derivative · entry 3 Stewart Richard Alistair · CIK 0001713369 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,500 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:31 UTC |
Stewart Richard AlistairDirector · Executive Chairman
|
Tax withholdingCommon Stock | 10,125 | $4.51 | $45,663.75 |
DisclosureSEC source: 0000950170-24-046962 · ownership.xml · nonDerivative · entry 2 Stewart Richard Alistair · CIK 0001713369 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,876 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:31 UTC |
Stewart Richard AlistairDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046962 · ownership.xml · nonDerivative · entry 1 Stewart Richard Alistair · CIK 0001713369 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:26 UTC |
Bencich JohnDirector · CEO
|
Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046936 · ownership.xml · derivative · entry 3 Bencich John · CIK 0001477056 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:26 UTC |
Bencich JohnDirector · CEO
|
Tax withholdingCommon Stock | 6,088 | $4.51 | $27,456.88 |
DisclosureSEC source: 0000950170-24-046936 · ownership.xml · nonDerivative · entry 2 Bencich John · CIK 0001477056 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,636 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:26 UTC |
Bencich JohnDirector · CEO
|
Exercise / conversionCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046936 · ownership.xml · nonDerivative · entry 1 Bencich John · CIK 0001477056 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:49 UTC |
Stewart Richard AlistairDirector · Executive Chairman
|
PurchaseCommon Stock Warrants (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-24-027261 · ownership.xml · derivative · entry 2 Stewart Richard Alistair · CIK 0001713369 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.expiration_date: The common shares reported on this Form 4 were purchased in a registered direct offering (the "RDO") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the "SPA") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the "Private Placement Warrants") . The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:49 UTC |
Stewart Richard AlistairDirector · Executive Chairman
|
PurchaseCommon Stock | 10,000 | $4.59 | $45,850.00 |
DisclosureSEC source: 0000950170-24-027261 · ownership.xml · nonDerivative · entry 1 Stewart Richard Alistair · CIK 0001713369 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,501 F1 · shares: The common shares reported on this Form 4 were purchased in a registered direct offering (the "RDO") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the "SPA") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the "Private Placement Warrants") . The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:43 UTC |
Bencich JohnDirector · CEO
|
PurchaseCommon Stock Warrants (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-24-027243 · ownership.xml · derivative · entry 2 Bencich John · CIK 0001477056 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.expiration_date: The common shares reported on this Form 4 were purchased in a registered direct offering (the "RDO") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the "SPA") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the "Private Placement Warrants") . The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:43 UTC |
Bencich JohnDirector · CEO
|
PurchaseCommon Stock | 10,000 | $4.59 | $45,850.00 |
DisclosureSEC source: 0000950170-24-027243 · ownership.xml · nonDerivative · entry 1 Bencich John · CIK 0001477056 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,724 F1 · shares: The common shares reported on this Form 4 were purchased in a registered direct offering (the "RDO") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the "SPA") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the "Private Placement Warrants") . The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence. F2 · balance_after: This number reflects a decrease of ownership of 6 shares of common stock from the number of shares previously reported due to an administrative error at the time of the Issuer's 1-for-20 split on July 31, 2020. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 00:22 UTC |
KING THOMAS BRAXTONDirector
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-24-002207 · doc4.xml · derivative · entry 1 KING THOMAS BRAXTON · CIK 0001279309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2034-01-22 F1 · derivative.exercise_date: The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 00:20 UTC |
Duty StuartDirector
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-24-002205 · doc4.xml · derivative · entry 1 Duty Stuart · CIK 0001970274 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2034-01-22 F1 · derivative.exercise_date: The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 00:09 UTC |
Sellig ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-24-002202 · doc4.xml · derivative · entry 1 Sellig Thomas · CIK 0001969416 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2034-01-22 F1 · derivative.exercise_date: The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 00:07 UTC |
HIMES VAUGHN BDirector
|
GrantStock Option (right to buy) · Derivative | 31,500 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-24-002200 · doc4.xml · derivative · entry 1 HIMES VAUGHN B · CIK 0001361966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 31,500 shares Expires 2034-01-22 F1 · derivative.exercise_date: The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.